GlassScriptPhysician profile
Susan S Nyquist
NPI 1639314925
$5,913.22
in general payments reported to CMS, 2019-2025
26 companies · $413 in 2025
The $413 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,540 · 2020: $78.82 · 2021: $187 · 2022: $1,647 · 2023: $492 · 2024: $555 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,460.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $3,852.10 | 2019-2025 | Tecnis Iol, Tecnis Simplicity |
| Allergan, INC. | $367.89 | 2019-2022 | |
| Lensar, INC. | $232.61 | 2022-2025 | Lensar Laser System |
| Sun Pharmaceutical Industries INC. | $166.46 | 2019-2024 | Cequa |
| Kala Pharmaceuticals, INC. | $158.10 | 2021 | |
| Bausch & Lomb Americas INC. | $158.04 | 2023-2024 | Xiidra, Miebo |
| Carl Zeiss Meditec, INC. | $154.17 | 2019-2024 | |
| Horizon Therapeutics Plc | $124.99 | 2023 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $119.93 | 2024 | Xdemvy |
| Rxsight INC | $105.06 | 2025 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Oyster Point Pharma, INC. | $72.60 | 2023-2024 | Tyrvaya |
| Glaukos Corporation | $71.02 | 2019-2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Novartis Pharmaceuticals Corporation | $54.93 | 2019-2023 | |
| Abbvie INC. | $48.70 | 2024 | |
| Johnson & Johnson Vision Care, INC. | $35.31 | 2023-2024 | Acuvue |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $29.45 | 2020-2024 | Rocklatan |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $26.26 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Thea Pharma INC. | $16.91 | 2024 | Iyuzeh |
| Omeros Corporation | $16.69 | 2020 | |
| Rayner Intraocular Lenses Limited | $15.27 | 2023 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Dompe US, INC. | $15.00 | 2019 | |
| Amgen INC. | $14.82 | 2024 | Tepezza |
| Harrow Eye, LLC | $13.90 | 2024 | Vevye |
| Shire North American Group INC | $13.72 | 2019 | |
| New World Medical,INC. | $9.89 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Nyquist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.